Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-03 | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana
(Chief Med and Dev Officer) |
S | Common Stock | D | 14375 | $54.63 - $54.63 | $785,306 |
| 2024-10-03 | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana
(Chief Med and Dev Officer) |
M | Common Stock | A | 14375 | $16.89 - $16.89 | $242,793 |
| 2024-09-26 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
S | Common Stock | D | 25000 | $51.11 - $51.11 | $1,277,750 |
| 2024-09-26 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
M | Common Stock | A | 25000 | $15.29 - $15.29 | $382,250 |
| 2024-07-25 | Crinetics Pharmaceuticals, Inc. | Betz Stephen F.
(Chief Scientific Officer) |
S | Common Stock | D | 3000 | $53.43 - $53.43 | $160,290 |
| 2024-07-25 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
S | Common Stock | D | 19056 | $53.88 - $53.88 | $1,026,737 |
| 2024-07-25 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
M | Common Stock | A | 19056 | $9.28 - $9.28 | $176,839 |
| 2024-07-15 | Crinetics Pharmaceuticals, Inc. | Knight Jeff E.
(Chief Operating Officer) |
S | Common Stock | D | 27000 | $55.00 - $55.00 | $1,485,000 |
| 2024-07-15 | Crinetics Pharmaceuticals, Inc. | Knight Jeff E.
(Chief Operating Officer) |
M | Common Stock | A | 26073 | $19.64 - $23.98 | $589,115 |
| 2024-07-15 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
S | Common Stock | D | 25000 | $55.00 - $55.00 | $1,375,000 |
| 2024-07-15 | Crinetics Pharmaceuticals, Inc. | Wilson Marc
(CFO) |
M | Common Stock | A | 25000 | $20.02 - $20.02 | $500,500 |
| 2024-07-05 | Crinetics Pharmaceuticals, Inc. | Hassard James
(Chief Commercial Officer) |
S | Common Stock | D | 15000 | $44.08 - $44.08 | $661,200 |
| 2024-07-05 | Crinetics Pharmaceuticals, Inc. | Hassard James
(Chief Commercial Officer) |
M | Common Stock | A | 15000 | $19.73 - $19.73 | $295,950 |
| 2024-07-03 | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana
(Chief Med and Dev Officer) |
S | Common Stock | D | 14375 | $44.87 - $44.87 | $645,006 |
| 2024-07-03 | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana
(Chief Med and Dev Officer) |
M | Common Stock | A | 14375 | $16.89 - $16.89 | $242,793 |
| 2024-06-26 | Crinetics Pharmaceuticals, Inc. | Knight Jeff E.
(Chief Operating Officer) |
S | Common Stock | D | 956 | $44.38 - $44.38 | $42,427 |
| 2024-06-25 | Crinetics Pharmaceuticals, Inc. | Betz Stephen F.
(Chief Scientific Officer) |
S | Common Stock | D | 3000 | $45.37 - $45.37 | $136,110 |
| 2024-06-24 | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana
(Chief Med and Dev Officer) |
S | Common Stock | D | 9500 | $45.73 - $45.73 | $434,434 |
| 2024-06-24 | Crinetics Pharmaceuticals, Inc. | Pizzuti Dana
(Chief Med and Dev Officer) |
M | Common Stock | A | 9500 | $16.89 - $16.89 | $160,455 |
| 2024-06-21 | Crinetics Pharmaceuticals, Inc. | Hassard James
(Chief Commercial Officer) |
S | Common Stock | D | 15000 | $44.66 - $44.66 | $669,900 |
| 2024-06-21 | Crinetics Pharmaceuticals, Inc. | Hassard James
(Chief Commercial Officer) |
M | Common Stock | A | 15000 | $19.73 - $19.73 | $295,950 |
| 2024-06-10 | Crinetics Pharmaceuticals, Inc. | Betz Stephen F.
(Chief Scientific Officer) |
S | Common Stock | D | 3000 | $43.86 - $43.86 | $131,580 |
| 2024-06-07 | Crinetics Pharmaceuticals, Inc. | Bedrosian Camille L
(Director) |
A | Common Stock | A | 3400 | $0.00 - $0.00 | $0 |
| 2024-06-07 | Crinetics Pharmaceuticals, Inc. | WIERENGA WENDALL
(Director) |
A | Common Stock | A | 3400 | $0.00 - $0.00 | $0 |
| 2024-05-28 | Crinetics Pharmaceuticals, Inc. | Betz Stephen F.
(Chief Scientific Officer) |
S | Common Stock | D | 3000 | $47.49 - $47.49 | $142,470 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |